Skip to main content
Clinical Trials/NCT04021303
NCT04021303
Unknown
Not Applicable

Study of the Initiation of Complementary Feeding With a Whole Grain, Gluten-containing Infant Cereal and PROBIOtics to Evaluate Digestive TOLERAance and Immuno-inflammatory Response at the Intestinal Level.

Laboratorios Ordesa1 site in 1 country172 target enrollmentSeptember 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gastrointestinal Disorder
Sponsor
Laboratorios Ordesa
Enrollment
172
Locations
1
Primary Endpoint
Digestive tolerance
Last Updated
5 years ago

Overview

Brief Summary

This study will assess the development of gastrointestinal health in terms of digestive tolerability and immune-inflammatory response at the intestinal level comparing a conventional gluten-free cereal with a new cereal with prebiotics, probiotics and a very moderate amount of gluten. These are products adapted to infant feeding since 4 Months.

Detailed Description

In 2008 the ESPGHAN recommended not to give gluten cereals before 4 months but not after 7 months. Although the introduction of gluten in this window was linked to a posible preventive effect on celiac disease, the truth is that it has not been demonstrated. In any case, high exposures to gluten since the 4 months have been associated with a higher incidence of celiac disease and current recommendations propose moderate and progressive exposure to gluten between 4 and 6 months old.

Registry
clinicaltrials.gov
Start Date
September 1, 2019
End Date
June 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Laboratorios Ordesa
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Healthy term infants (\>37 weeks) vaginal delivery
  • Adequate birth weight for gestational age (10-90 percentile)
  • Infants with normal growth curve (10-90 percentile)
  • Infants who were breastfeeding for at least 4 weeks, and at least half of the takes have been by breastfeeding.
  • Infants aged 4 months (+/- 1 week) at the time of study inclusion no longer following breastfeeding, or mixed breastfeeding and if they are breast-feeding, no more than one shot a day.
  • Availability to continue throughout the study period.
  • Signature of informed consent by partents/guardians.

Exclusion Criteria

  • Infants who were born by cesarean section
  • Infants born from preconception obese mothers
  • Infants born from diabetic mothers or mothers with gestational diabetes
  • Infants with a family history of celiac disease (parents or siblings)
  • Infants who have had or have some type of allergic manifestation or allergic pathology
  • Infants who have needed antibiotic treatment or have received some type of probiotic (the week before inclusion)
  • Infants with malformations, diseases or conditions and physical disabilities that cause changes in growth and/or nutritional status
  • Infants diagnosed with any immune system-related disease (primary immunodeficiency)
  • Infants with a known allergy and/or intolerance to cow's milk protein
  • Parents' inability to follow study (at the discretion of the researcher)

Outcomes

Primary Outcomes

Digestive tolerance

Time Frame: From 4 to 12 months old

Infant Gastrointestinal Symptom Questionnaire (IGSQ) developed by Riley et al. to be completed by parents/guardians. It contains 13 ítems.For each item there are 5 possible answers in gradation 1 to 5 points and the result is the sum of all of them with minimum scores of 13 (maximum health status) and maximum of 65

Secondary Outcomes

  • Assessing infant feeding habits(At 4, 5, 6, 9 and 12 months old)
  • Infant microbiota study(Stool sample collected at 4, 6 and 12 months old.)
  • Assessment of intestinal health(Stool sample collected at 4, 6 and 12 months old.)
  • Assessment of immune-inflammatory response(At 4, 6 and 12 months old.)
  • Infant infection episodes(At 4, 5, 6, 9 and 12 months old.)
  • Assessment of infant growth: weight(At 4, 5, 6, 9 and 12 months old.)
  • Assessment of infant growth: lenght(At 4, 5, 6, 9 and 12 months old.)
  • Assessment of infant growth: cephalic perimeter(At 4, 5, 6, 9 and 12 months old.)
  • Evolution of body composition(At 4, 5, 6, 9 and 12 months old)
  • Medical history(At 4 months old)
  • Demographics(At 4 months old)

Study Sites (1)

Loading locations...

Similar Trials